782493-57-6

Basic information

• Product Name: 1-Piperidinecarboxylic acid, 4-(2-amino-2-oxoethyl)-, 1,1-dimethylethyl ester
• Synonyms: 1-Piperidinecarboxylic acid, 4-(2-amino-2-oxoethyl)-, 1,1-dimethylethyl ester
• CAS NO: 782493-57-6
• Molecular Formula: C₁₂H₂₂N₂O₃
• Molecular Weight: 242.31468
• Mol File: 782493-57-6.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 403.2±18.0 °C(Predicted)
• Appearance: /
• Density: 1.086±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 16.48±0.40(Predicted)
• CAS DataBase Reference: 1-Piperidinecarboxylic acid, 4-(2-amino-2-oxoethyl)-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Piperidinecarboxylic acid, 4-(2-amino-2-oxoethyl)-, 1,1-dimethylethyl ester(782493-57-6)
• EPA Substance Registry System: 1-Piperidinecarboxylic acid, 4-(2-amino-2-oxoethyl)-, 1,1-dimethylethyl ester(782493-57-6)

Safety Data

• Hazardous Substances Data: 782493-57-6(Hazardous Substances Data)

Usage

General Description

1-Piperidinecarboxylic acid, 4-(2-amino-2-oxoethyl)-, 1,1-dimethylethyl ester is a chemical compound with the molecular formula C14H26N2O3. It is an ester derived from piperidinecarboxylic acid, aminooxoethyl, and 1,1-dimethylethanol. 1-Piperidinecarboxylic acid, 4-(2-amino-2-oxoethyl)-, 1,1-dimethylethyl ester is commonly used in organic synthesis and pharmaceutical research, and it is known for its ability to act as a substrate or inhibitor for certain enzymes. It may also have potential applications in the development of new drugs and pharmaceuticals due to its structural properties and reactivity. Overall, this compound is of interest to researchers and chemists for its potential uses in various fields of science and medicine.

Upstream product

• 157688-46-5 2-(1-(tert-butoxycarbonyl)piperidin-4-yl)acetic acid 
• 543-27-1 isobutyl chloroformate 
• 883877-26-7 C₁₇H₂₉NO₆ 

Downstream Products

• 280110-63-6 (Z)-tert-butyl 4-(N’-hydroxycarbamimidoyl)piperidine-1-carboxylate 
• 256411-39-9 tert-butyl 4-(cyanomethyl)piperidine-1-carboxylate 

Relevant articles and documents

Search for potent and selective Aurora A inhibitors based on general Ser/Thr kinase pharmacophore model

Based on the data for compounds known from the literature to be active against various types of Ser/Thr kinases, a general pharmachophore model for these types of kinases was developed. The search for the molecules fitting to this pharmacophore among the ASINEX proprietary library revealed a number of compounds, which were tested and appeared to possess some activity against Ser/Thr kinases such as Aurora A, Aurora B and Haspin. Our work on the optimization of these molecules against Aurora A kinase allowed us to achieve several hits in a 3-5 nM range of activity with rather good selectivity and Absorption, Distribution, Metabolism, and Excretion (ADME) properties, and cytotoxicity against 16 cancer cell lines. Thus, we showed the possibility to fine-tune the general Ser/Thr pharmacophore to design active and selective compounds against desired types of kinases.

NOVEL COMPOUNDS USEFUL AS S100-INHIBITORS

A compound of formula (I) or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising the compound. The compound is an inhibitor of interactions between S100A9 and interaction partners such as RAGE, TLR4 and EMMPRIN and as such is useful in the treatment of disorders such as cancer, autoimmune disorders, inflammatory disorders and neurodegenerative disorders.

BENZOXAZINYL-AMIDOCYCLOPENTYL-HETEROCYCLIC MODULATORS OF CHEMOKINE RECEPTORS

Cyclopentyl compounds linked to a benzoxazinyl group through an amido moiety utilizing the ring nitrogen of the benzoxazine, and further substituted with a heterocyclic moiety, such compounds represented by formula (I): which are used to modulate the CCR-